Executive Summary

Oct 2019
PROSPECTS
The ageing of the Danish population to contribute to growth in analgesics

Denmark has an ageing population and the proportion of the country’s population aged 65 and over increased steadily over the course of the review period. This is because chronic mild to moderate pain remains prevalent among the older population.

Innovation and new product development spur category growth

Product differentiation remained an important strategy for the leading players in analgesics in 2019 as they focused on the development of new products that offer specific benefits in addition to basic pain relief and this is likely to continue driving growth in analgesics during the forecast period. One example of an innovative new products seen in the category during 2019 is Panodil Extra by GSK Consumer Healthcare, which combines paracetamol and caffeine to provide relief from pain and fever while at the same time providing extra energy.

Systemic diclofenac remains Rx-only as researchers warn of potential side effects

2019 saw systemic diclofenac remain scheduled as a prescription-only medicine as Danish researchers continued to warn against the potential for serious side-effects from diclofenac in tablet form. One recent study has shown that systemic diclofenac can increase the risk of cardiovascular disease.

COMPETITIVE LANDSCAPE
Sales of analgesics remain highly consolidated

Analgesics remains a highly consolidated OTC category in Denmark as consumers tend to be more willing to place their trust in well-known brands that can guarantee a supply of safe, high-quality products. The result of this general preference for leading brands is that the category’s top three players GlaxoSmithKline Consumer HealthCare A/S, Takeda Pharma A/S and Meda A/S account for well over three-quarters of retail value sales.

Grocery retailers continues to gain ground, at the expense of chemists/pharmacies

2019 saw sales of analgesics through modern grocery retailers continue to increase, while sales through chemists/pharmacies continued to decline. The basis of this trend is that more Danes are purchasing OTC medication while doing their grocery shopping.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Denmark

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Denmark with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Denmark, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Denmark market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Denmark?
  • What are the major brands in Denmark?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Denmark - Category analysis

HEADLINES

PROSPECTS

The ageing of the Danish population to contribute to growth in analgesics
Innovation and new product development spur category growth
Systemic diclofenac remains Rx-only as researchers warn of potential side effects

COMPETITIVE LANDSCAPE

Sales of analgesics remain highly consolidated
Grocery retailers continues to gain ground, at the expense of chemists/pharmacies

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Denmark - Industry Overview

EXECUTIVE SUMMARY

Positive growth continues as consumer health benefits from prevailing consumer trends
Sales growth accelerates again in 2019 due to favourable lifestyle and demographic factors
GSK Consumer Health and Orkla Care remain the leading players
The shift towards online sales continues in non-regulated categories
Few changes expected to be seen in a stable and settled industry

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources

Consumer Health in Denmark - Industry Overview

EXECUTIVE SUMMARY

Positive growth continues as consumer health benefits from prevailing consumer trends
Sales growth accelerates again in 2019 due to favourable lifestyle and demographic factors
GSK Consumer Health and Orkla Care remain the leading players
The shift towards online sales continues in non-regulated categories
Few changes expected to be seen in a stable and settled industry

MARKET INDICATORS

Table 18 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 19 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 20 Sales of Consumer Health by Category: Value 2014-2019
Table 21 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 22 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 23 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 24 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 25 Distribution of Consumer Health by Format: % Value 2014-2019
Table 26 Distribution of Consumer Health by Format and Category: % Value 2019
Table 27 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 28 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 2 Research Sources